KYKarin Yamada
Karin Yamada
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karin Yamada has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Domenica Lorusso
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
2 shared publications - Elizabeth A. Szamreta
Merck & Co Inc, Rahway, NJ, USA
2 shared publications - Alejandro Acevedo
Oncocentro, Valparaiso, Chile
1 shared publication - Allison Martin Nguyen
Merck & Co., Inc., Rahway, NJ, USA
1 shared publication - Angélica Nogueira-Rodrigues
Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
1 shared publication Chien-Jhih Tsai
Lumanity, London, UK
1 shared publication
Latest Publications
- Open Access
- 19 May 2026
- Published by Elsevier in Gynecologic Oncology
- Vol. 210, 1-9
Cost-effectiveness of pembrolizumab as a treatment for FIGO 2014 stage III–IVA cervical cancer in the United States
- 19 May 2026
- Published by Elsevier in Gynecologic Oncology
- Vol. 210, 1-9
Open AccessCost-effectiveness of pembrolizumab as a treatment for FIGO 2014 stage III–IVA cervical cancer in the United States
- Open Access
- 1 July 2025
- Published by Elsevier in Gynecologic Oncology
- Vol. 199, 88-95
Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer
- 1 July 2025
- Published by Elsevier in Gynecologic Oncology
- Vol. 199, 88-95
Open AccessPatient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer